This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Concert Pharmaceuticals, Inc. [CNCE] To Ring The NASDAQ Stock Market Opening Bell

ADVISORY, April 11, 2014 (GLOBE NEWSWIRE) --


Concert Pharmaceuticals, Inc. [CNCE], a clinical stage biopharmaceutical company creating novel drugs for CNS disorders, renal disease, inflammation and cancer, will visit the NASDAQ MarketSite in Times Square.

In honor of the occasion, Dr. Roger Tung, Chief Executive Officer will ring the Opening Bell.


NASDAQ MarketSite – 4 Times Square – 43 rd & Broadway – Broadcast Studio


Monday, April 14, 2014 – 9:15 a.m. to 9:30 a.m. ET        

Concert Pharmaceuticals, Inc. Contact: Justine Koenigsberg (781) 860-0045

NASDAQ MarketSite: Christine Barna (646) 441-5310

Feed Information: Fiber Line (Encompass Waterfront): 4463

Gal 3C/06C 95.05 degrees West 18 mhz Lower DL 3811 Vertical FEC 3/4 SR 13.235 DR 18.295411 MOD 4:2:0 DVBS QPSK

Social Media:

For multimedia features such as exclusive content, photo postings, status updates and video of bell ceremonies please visit our Facebook page at:

For photos from ceremonies and events visit our Instagram Page:

For news tweets, please visit our Twitter page at:

For exciting viral content and ceremony photos visit Tumblr Page:


A webcast of the NASDAQ Opening Bell will be available at: or


To obtain a hi-resolution photograph of the Market Open, please go to and click on the market open of your choice.

About Concert Pharmaceuticals, Inc. [CNCE]:

Concert Pharmaceuticals is a clinical stage biopharmaceutical company focused on applying its DCE Platform® (deuterated chemical entity platform) to create novel small molecule drugs. This approach starts with approved drugs, advanced clinical candidates or previously studied compounds that have the potential to be improved with deuterium substitution to enhance clinical safety, tolerability and efficacy. The company is developing a broad pipeline targeting CNS disorders, renal disease, inflammation and cancer.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 16,790.19 +13.76 0.08%
S&P 500 1,979.92 -7.13 -0.36%
NASDAQ 4,748.3610 -32.9030 -0.69%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs